Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Background: Cytoreductive nephrectomy (CN) became a standard procedure in metastatic renal cell carcinoma (mRCC) in the immunotherapy era. Historically, median overall survival (OS) of patients treated with interferon alpha (IFN-α) without CN was 7.8 months. Median OS in patients treated with target...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Richey, S. L., Culp, S. H., Jonasch, E., Corn, P. G., Pagliaro, L. C., Tamboli, P., Patel, K. K., Matin, S. F., Wood, C. G., Tannir, N. M.
Format:	Artigo
Sprog:	Inglês
Udgivet:	Oxford University Press 2011
Fag:	Original Articles
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4092250/ https://ncbi.nlm.nih.gov/pubmed/21115604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdq563
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Lignende værker